As Alzheimer’s Awareness Month begins, health advocates and researchers are drawing renewed attention to a troubling reality: Black Americans continue to face a disproportionately high burden of Alzheimer’s disease and other forms of dementia, yet they remain underrepresented in research studies and often encounter barriers to diagnosis and treatment.

Alzheimer’s disease, the most common form of dementia, affects memory, thinking, and behavior. According to the Centers for Disease Control and Prevention, Alzheimer’s is not a normal part of aging and currently affects millions of older adults across the United States. The disease is expected to become an even greater public health challenge as the nation’s population ages.

The impact on Black communities is especially significant. The Alzheimer’s Association reports that older Black Americans are approximately twice as likely as older White Americans to develop Alzheimer’s disease or related dementias. Researchers believe the disparity is influenced by a combination of factors, including higher rates of cardiovascular disease, diabetes, hypertension, inequities in healthcare access, and longstanding social determinants of health.

“Optimizing health for the U.S. population requires eliminating disparities and addressing social determinants of health,” the Alzheimer’s Association notes in its health equity framework. The organization has identified Black Americans as one of the populations disproportionately affected by dementia and cognitive decline.

The numbers suggest the challenge will only grow. According to the Alzheimer’s Association’s 2026 Facts and Figures report, an estimated 7.4 million Americans age 65 and older are currently living with Alzheimer’s dementia. As the population continues to age, that figure is expected to increase substantially in the coming decades.

For many Black families, the disease carries a unique burden. Caregiving responsibilities often fall on relatives who may already be managing work, financial obligations, and chronic health conditions of their own. Studies have also found that Black patients are less likely to receive a timely dementia diagnosis, potentially delaying access to care, support services, and treatment options.

Health experts say early diagnosis remains critical. The CDC notes that recognizing symptoms early can help families access treatments that may slow progression, participate in clinical trials, and make important financial and care-planning decisions. Common warning signs include increasing memory loss, difficulty completing familiar tasks, confusion about time or place, and changes in judgment or personality.

Closing the Research Gap

One area receiving increased attention this Alzheimer’s Awareness Month is the lack of diversity in clinical research. Historically, Black Americans have been underrepresented in many Alzheimer’s studies despite experiencing a higher disease burden. Researchers and advocacy organizations argue that greater participation is essential to ensure new treatments and diagnostic tools are effective across diverse populations.

Among the organizations working to address that gap is the National Minority Quality Forum. Earlier this year, NMQF announced an expansion of its Clinical Trial Learning Community model to focus specifically on Alzheimer’s disease. The initiative aims to identify barriers to clinical trial participation, improve trust in research, and increase access to studies among historically underserved populations.

According to NMQF, the effort is designed to ensure that clinical trial enrollment better reflects the populations most affected by the disease. The organization has emphasized that reducing disparities in Alzheimer’s outcomes requires both equitable access to care and meaningful representation in research.

The focus on equity comes at a pivotal moment. The CDC has noted that conditions such as hypertension, diabetes, physical inactivity, and limited healthcare access are linked to increased dementia risk and are more common among several historically marginalized populations. Public health experts increasingly view Alzheimer’s through the lens of health equity, recognizing that community-level factors can influence both risk and outcomes.

Throughout Alzheimer’s Awareness Month, advocacy groups, healthcare providers, and community organizations are encouraging Black families to learn the warning signs of dementia, discuss family health history with healthcare professionals, and explore opportunities to participate in research. While scientists continue searching for better treatments and ultimately a cure, experts say awareness, early detection, and equitable access to care remain among the most powerful tools available today.

As Alzheimer’s cases continue to rise nationwide, advocates argue that addressing the disease in Black communities is not simply a matter of improving individual health outcomes. It is a broader effort to close longstanding healthcare gaps and ensure that every family has access to the knowledge, resources, and research opportunities needed to confront one of America’s fastest-growing health challenges. Visit https://talkaboutalz.org/ today to have a heart-to-heart conversation about Alzheimer’s.